EcoDrugPlus

Retinoic Acid Receptor Gamma

Ensembl ID : ENSOMEG00000016231
Gene Symbol: RARG
4 Cross references
353 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSOMEG00000021502
Gene Symbol: LOC112145266
3 Cross references
377 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSOMEG00000000512
Gene Symbol: RXRA
3 Cross references
225 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2a

Ensembl ID : ENSOMEG00000010220
Gene Symbol: ROCK2A
1 Cross references
225 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSOMEG00000020096
Gene Symbol: RPL10A
3 Cross references
369 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSOMEG00000006909
Gene Symbol: RPL11
1 Cross references
217 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSOMEG00000003330
Gene Symbol: RPL12
1 Cross references
479 Possible Orthologues:

Ribosomal Protein L13

Ensembl ID : ENSOMEG00000001728
Gene Symbol: RPL13
3 Cross references
275 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSOMEG00000010232
Gene Symbol: RPL13A
3 Cross references
368 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSOMEG00000000311
Gene Symbol: RPL14
3 Cross references
309 Possible Orthologues:

Ribosomal Protein L15

Ensembl ID : ENSOMEG00000020068
Gene Symbol: RPL15
3 Cross references
357 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSOMEG00000005081
Gene Symbol: RPL17
3 Cross references
710 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).